GSK PLC Transfer of Treasury Shares (5125I)
December 05 2022 - 11:00AM
UK Regulatory
TIDMGSK
RNS Number : 5125I
GSK PLC
05 December 2022
GSK plc
(the 'Company')
Transfer of Treasury Shares
On 1 December 2022, the Company transferred 26,800,000 ordinary
shares of 31 1/4 pence each ("Ordinary Shares") that were held by
the Company in treasury ("Treasury Shares") to JPMorgan Chase Bank,
N.A. the depositary of the Company's American depositary receipts
("ADR") programme, to procure the issuance and transfer of
13,400,000 ADRs of the Company to the GlaxoSmithKline (US) Trust
(the "Trust"), to be used to satisfy awards granted under the
Company's Deferred Annual Bonus Plan, Performance Share Plan and
Share Value Plan. The consideration received from the trustee of
the Trust of $34.590 per ADR, representing $17.295 per Ordinary
Share, was funded by a contribution to the Trust from
GlaxoSmithKline LLC.
Following the transfer and as at 2 December 2022, the Company's
issued share capital consisted of 4,311,323,691 Ordinary Shares, of
which 217,124,760 were held as Treasury Shares.
Therefore, the total number of voting rights in the Company is
4,094,198,931. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules .
Notifications may be sent to company.secretary@gsk.com .
V A Whyte
Company Secretary
5 December 2022
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSFLFIAFLLFIIF
(END) Dow Jones Newswires
December 05, 2022 11:00 ET (16:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024